<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Calcium-related mechanisms are an integral part of metabolic reactions during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In an animal model of <z:hpo ids='HP_0001297'>stroke</z:hpo>, the calcium <z:chebi fb="68" ids="48706">antagonist</z:chebi> isradipine was shown to protect neurons against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In order to improve the neurological and functional outcome of human <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, a randomised, double-blind, placebo-controlled multicentre study was started in up to 600 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> ischaemic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Since early treatment is considered to be of great importance, patients must be recruited no more than 12 hours after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Medical, ECG, laboratory, neurological and functional evaluations are conducted for up to 90 days after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>